International Journal of Cardiovascular ResearchISSN: 2324-8602

Reach Us +1 850 900 2634
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Research Article, Int J Cardiovasc Res Vol: 3 Issue: 1

Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

Vladimir I Morozov1*, Michael I Kalinski2, Jason Jaggers2, Nikolay V Goncharov1 and Galina A Sakuta3
1Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Saint-Petersburg, Russia
2Murray State University, Murray, KY, USA
3Institute of Cytology of the Russian Academy of Sciences, Saint-Petersburg, Russia
Corresponding author : Vladimir I Morozov
Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences, Ave Torez 44, 194223 St-Petersburg, Russia
Tel: +7 (812) 552-7901; Fax: +7 (812) 552- 3012
E-mail: [email protected]
Received: December 13, 2013 Accepted: February 14, 2014 Published: February 25, 2014
Citation: Morozov VI, Kalinski MI, Jaggers J, Goncharov NV, Sakuta GA (2014) Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage. Int J Cardiovasc Res 3:1. doi:10.4172/2324-8602.1000157

Abstract

Ischemia-Modified Albumin as a Marker of Myocardium and Skeletal Muscle Damage

This is an overview of literature data on ischemia-modified albumin (IMA) and its potential as a marker of myocardium and skeletal muscle damage. Characteristics and properties of IMA are considered. IMA can be used as a nonspecific variable of ischemic conditions but IMA fails to differentiate between ischemic tissues. As a marker of ischemic conditions IMA may be used in combinations with other markers.

Keywords: Ischemia-modified albumin; Biomarker; Myocardium and Skeletal muscle damage

Track Your Manuscript

Share This Page

Media Partners